Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Cell-Based Therapy
  • Published:

Cell-Based Therapy

Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice

Gene Therapy volume 7, pages 348–358 (2000)Cite this article

Abstract

The MDR1 (multidrug resistance) gene, transferred to hematopoietic cells, is expected to protect them from anticancer chemotherapy and may serve as a selectable marker, restoring gene expression in vivo. Appropriate selection strategies, however, need to be established. To investigate whether preselection ex vivo affects chemoresistance, murine bone marrow cells were retrovirally transduced with high-titer or, as a model for suboptimal gene expression, low-titer retroviruses and exposed to daunomycin or colchicine for 48–96 h. Selection significantly increased chemoresistance of clonogenic progenitor cells. In tissue culture, the entire target population was rendered highly drug resistant after MDR1 transfer with high-titer viruses. If transduction was performed under suboptimal conditions, drug selection increased the frequency of chemoresistant colonies up to 40% over the number of unselected cells. Colchicine and daunomycin were equally efficient in increasing drug resistance ex vivo, but colchicine-preselected cells rescued lethally irradiated mice under conditions where daunomycin-selected bone marrow cells failed to do so. Hence, while hematopoietic cells can be protected by MDR1, the selection strategy is critical for repopulation of bone marrow with transduced cells. Preselection in culture before transplantation significantly increased P-gp expression and chemoresistance in vivo in mice reconstituted with transduced bone marrow cells. This study may help to facilitate the use of MDR1 as a selectable marker in gene therapy of the hematopoietic system.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Klimecki WT, Futscher BW, Grogan TM, Dalton WS . P-glycoprotein expression and function in circulating blood cells from normal volunteers Blood 1994 83: 2451–2458

    CAS  Google Scholar 

  2. Drach D et al. Subpopulations of normal and peripheral blood and bone marrow cells express a functional multidrug resistant phenotype Blood 1992 80: 2735–2739

    Google Scholar 

  3. Chaudhary PM, Roninson IB . Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells Cell 1991 66: 85–94

    Article  CAS  Google Scholar 

  4. Chaudhary PM, Mechetner EB, Roninson IB . Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes Blood 1992 80: 2729–2734

    Google Scholar 

  5. Gottesman MM, Pastan I . Biochemistry of multidrug resistance mediated by the multidrug transporter Annu Rev Biochem 1993 62: 385–427

    Article  CAS  Google Scholar 

  6. Goldstein L et al. Expression of a multidrug resistance gene in human cancers J Natl Cancer Inst 1989 81: 116–124

    Article  CAS  Google Scholar 

  7. Pirker R et al. MDR1 RNA expression is an independent prognostis factor in acute myeloid leukemia Blood 1992 80: 557–559

    CAS  PubMed  Google Scholar 

  8. Baldini N et al. Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome New Engl J Med 1995 333: 1380–1385

    Article  CAS  Google Scholar 

  9. Gottesman MM, Pastan I . The multidrug resistance (MDR1) gene as a selectable marker in gene therapy. In: Cohen-Haguenauer O, Boiron M (eds). Human Gene Transfer, vol.219. Coloque INSERM/John Libbey Eurotext: London 1991 pp 185–191

  10. Banerjee D et al. Gene therapy utilizing drug resistance genes: a review Stem Cells 1994 12: 378–385

    Article  CAS  Google Scholar 

  11. Licht T, Pastan I, Gottesman MM, Herrmann F . The multidrug resistance gene in gene therapy of cancer and hematopoietic disorders Ann Hematol 1996 72: 184–193

    Article  CAS  Google Scholar 

  12. Hanania EG et al. Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy Proc Natl Acad Sci USA 1996 93: 15346–15351

    Article  CAS  Google Scholar 

  13. Hesdorffer C et al. Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation J Clin Oncol 1998 16: 165–172

    Article  CAS  Google Scholar 

  14. Cowan K et al. Paclitaxel chemotherapy after autologous stem cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary (MDR1) in metastatic breast cancer patients Clin Cancer Res 1999 5: 1619–1628

    CAS  Google Scholar 

  15. Moscow JA et al. Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy Blood 1999 94: 52–61

    CAS  Google Scholar 

  16. Galski H et al. Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: resistance to daunomycin induced leukopenia Mol Cell Biol 1989 9: 4357–4363

    Article  CAS  Google Scholar 

  17. Mickisch GH et al. Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency and toxicity Cancer Res 1991 51: 5417–5424

    CAS  Google Scholar 

  18. Podda S et al. Transfer and expression of the human multiple drug resistance gene into live mice Proc Natl Acad Sci USA 1992 89: 9676–9680

    Article  CAS  Google Scholar 

  19. Sorrentino BP et al. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1 Science 1992 257: 99–103

    Article  CAS  Google Scholar 

  20. Bodine DM et al. Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor Blood 1994 84: 1482–1491

    CAS  PubMed  Google Scholar 

  21. Hanania EG, Deisseroth AB . Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model Cancer Gene Ther 1994 1: 21–25

    CAS  PubMed  Google Scholar 

  22. Licht T, Aksentijevich I, Gottesman MM, Pastan I . Efficient expression of functional human MDR1 gene in murine bone marrow after retroviral transduction of purified hematopoietic stem cells Blood 1995 86: 111–121

    CAS  PubMed  Google Scholar 

  23. Ward M et al. Transfer and expression of the human multiple drug resistance gene in human CD34+ cells Blood 1994 84: 1408–1414

    CAS  PubMed  Google Scholar 

  24. Bertolini F et al. Retrovirus-mediated transfer of the multidrug resistance gene into human haematopoietic progenitor cells Br J Haematol 1994 88: 318–324

    Article  CAS  Google Scholar 

  25. Fruehauf S et al. Frequency analysis of multidrug resistance-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area-forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine-123 Hum Gene Ther 1996 7: 1219–1231

    Article  CAS  Google Scholar 

  26. Gottesman MM et al. Genetic analysis of the multidrug transporter Annu Rev Genet 1995 29: 607–649

    Article  CAS  Google Scholar 

  27. Aran JM, Gottesman MM, Pastan I . Drug-selected coexpression of human glucocerebrosidase and P-glycoprotein using a bicistronic vector Proc Natl Acad Sci USA 1994 91: 3176–3180

    Article  CAS  Google Scholar 

  28. Sugimoto Y et al. Retroviral co-expression of a multidrug-resistance gene (MDR1) and human alpha-galactosidase A for gene therapy of Fabry disease Hum Gene Ther 1995 6: 905–915

    Article  CAS  Google Scholar 

  29. Germann UA, Chin K-V, Pastan I, Gottesmann MM . Retroviral transfer of a chimeric multidrug resistance-adenosine deaminase gene FASEB J 1990 4: 1501–1507

    Article  CAS  Google Scholar 

  30. Sokolic RA et al. A bicistronic retrovirus vector containing a picornavirus internal ribosome entry site allows for correction of X-linked CGD by selection for MDR1 expression Blood 1996 87: 42–50

    CAS  PubMed  Google Scholar 

  31. Aran JM, Licht T, Gottesman MM, Pastan I . Complete restoration of glucocerebrosidase deficiency in Gaucher fibroblasts using a bicistronic MDR retrovirus and a new selection strategy Hum Gene Ther 1996 7: 2165–2175

    Article  CAS  Google Scholar 

  32. Blau CA, Neff T, Papayannopoulou T . Cytokine prestimulation as a gene therapy strategy: implications for using the MDR1 gene as a dominant selectable marker Blood 1997 89: 146–154

    CAS  PubMed  Google Scholar 

  33. Licht T et al. Retroviral transfer of human MDR1 gene to hematopoietic cells: effects of drug selection and of transcript splicing on expression of encoded P-glycoprotein Hum Gene Ther 1999 10: 2173–2185

    Article  CAS  Google Scholar 

  34. Zijlmans JM et al. The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells Proc Natl Acad Sci USA 1998 95: 725–729

    Article  CAS  Google Scholar 

  35. Uchida N et al. Rapid and sustained hematopoietic recovery in lethally irradiated mice transplanted with purified Thy-1.1lo Lin-Sca-1+ hematopoietic stem cells Blood 1994 83: 3758–3779

    CAS  PubMed  Google Scholar 

  36. Capel B et al. Clonal contributions of small numbers of retrovirally marked hematopoietic stem cells engrafted in unirradiated neonatal mice Proc Natl Acad Sci USA 1989 86: 4564–4568

    Article  CAS  Google Scholar 

  37. Snodgrass R, Keller G . Clonal fluctuation within the hematopoietic system of mice reconstituted with retrovirus-infected cells EMBO J 1987 6: 3955–3960

    Article  CAS  Google Scholar 

  38. Bunting KD et al. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice Blood 1998 92: 2269–2279

    CAS  Google Scholar 

  39. Yonemura Y et al. Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells Proc Natl Acad Sci USA 1996 93: 4040–4044

    Article  CAS  Google Scholar 

  40. Peters SO, Kittler EL, Ramshaw HS, Quesenberry PJ . Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts Blood 1996 87: 30–37

    CAS  Google Scholar 

  41. Brugger W et al. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin Blood 1993 81: 2579–2584

    CAS  Google Scholar 

  42. Sorrentino BP, McDonagh KT, Woods D, Orlic D . Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice Blood 1995 86: 491–501

    CAS  Google Scholar 

  43. McLachlin JR et al. Expression of a human complementary DNA for the human multidrug resistance gene in murine hematopoietic precursor cells with the use of retroviral gene transfer J Natl Cancer Inst 1990 82: 1260–1263

    Article  CAS  Google Scholar 

  44. Eckert HG et al. High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors Blood 1996 88: 3407–3415

    CAS  PubMed  Google Scholar 

  45. Safa AR et al. Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185–Val-185 substitution in P-glycoprotein Proc Natl Acad Sci USA 1990 87: 7225–7229

    Article  CAS  Google Scholar 

  46. Cardarelli CO, Aksentijevich I, Pastan I, Gottesman MM . Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters Cancer Res 1995 55: 1086–1091

    CAS  PubMed  Google Scholar 

  47. Richardson C, Bank A . Preselection of transduced murine hematopoietic stem cell populations leads to increased long-term stability and expression of the human multiple drug resistance gene Blood 1995 86: 2579–2589

    CAS  PubMed  Google Scholar 

  48. Davis BM et al. Selection for G156A O6-methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and protection from lethality in mice treated with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea Cancer Res 1997 57: 5093–5099

    CAS  Google Scholar 

  49. Flasshove M et al. Ex vivo expansion and selection of human CD34-positive peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer Blood 1995 85: 556–574

    Google Scholar 

  50. Zhao SC, Banerjee D, Mineishi S, Bertino JR . Post-transplant methotrexate administration leads to improved curability of mice bearing a mammary tumor transplanted with marrow transduced with a mutant human dihydrofolate reductase cDNA Hum Gene Ther 1997 8: 903–909

    Article  CAS  Google Scholar 

  51. Allay JA et al. In vivo selection of retrovirally transduced hematopoietic stem cells Nature Med 1998 4: 1136–1143

    Article  CAS  Google Scholar 

  52. Pastan I et al. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells Proc Natl Acad Sci USA 1988 85: 4486–4490

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    T Licht & I Pastan

  2. Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    S K Goldenberg, W D Vieira & M M Gottesman

Authors
  1. T Licht
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S K Goldenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W D Vieira
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M M Gottesman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I Pastan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Licht, T., Goldenberg, S., Vieira, W. et al. Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice. Gene Ther 7, 348–358 (2000). https://doi.org/10.1038/sj.gt.3301087

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301087

Keywords

This article is cited by

Search

Advanced search

Quick links